Saul, E. E., Chohan, K., Davis, R., Hagemeister, F. B., Steiner, R., Fayad, L., Ahmed, S., Rodríguez, M., Iyer, S., Nair, R., Vega, F., Chihara, D., Strati, P., Jain, P., Malpica, L., Nze, C., Furqan, F., Chauhan, A., Hamilton, M., Henderson, J., Lionel, A., Flowers, C., Neelapu, S., Green, M. R., Westin, J. (2025). Long-term clinical outcomes from the smart start trial: Rituximab, lenalidomide and ibrutinib in patients with newly diagnosed large B-cell lymphoma. Blood. https://doi.org/10.1182/blood-2025-3691